Document is current
Any future updates will be listed below
-
Authors
Smith, Alexander L. W.
Hamilton, Sorcha
Murphy, Susannah E.
Cowen, Philip J.
Harmer, Catherine J.
- License Information
-
More Information
Article History
Received: 18 March 2024
Accepted: 27 February 2025
First Online: 14 March 2025
Declarations
:
: The study was approved by Local Research Ethics Committee (Oxford, MSD-IDREC reference R79236/RE006).
: CJH has received consultancy fees from P1vital Ltd., Janssen Pharmaceuticals, Sage Therapeutics, Pfizer, Zogenix, Compass Pathways and Lundbeck. SEM has received consultancy fees from Zogenix, Sumitomo Dainippon Pharma, P1vital Ltd. and Janssen Pharmaceuticals. CJH and SEM hold grant income from Zogenix, UCB Pharma, Syndesi and Janssen Pharmaceuticals. CJH and PJC hold grant income from a collaborative research project with Pfizer and the MRC.
